2171
A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115)
Condition(s):Painful Diabetic NeuropathyLast Updated:July 27, 2015Withdrawn
Norepinephrine: 2230 Clinical Trials, Page 218 of 223
Hide Studies Not Open or Pending
2172
Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients
Condition(s):Depression; Adverse Reaction to DrugLast Updated:December 31, 2015Unknown status
2173
Development of Pharmacogenomic Method to Predict Antidepressant Responsiveness
Condition(s):Depression; Antidepressant Drug Adverse ReactionLast Updated:December 31, 2015Unknown status
2174
Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder
Condition(s):Major Depressive DisorderLast Updated:June 21, 2011Completed
2175
Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Condition(s):Major Depressive DisorderLast Updated:February 29, 2016Completed
2176
Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients
Condition(s):Major Depressive Disorder; Treatment Resistant DepressionLast Updated:May 23, 2012Completed
2177
Patient Dimensions as Predictors of Varied Treatment Responses and Outcomes in Patients With Major Depression
Condition(s):Depression; Major Depressive DisorderLast Updated:September 1, 2008Completed
2178
A Study Evaluating Desvenlafaxine Sustained Release (DVS SR) in Adult Female Outpatients With Fibromyalgia
Condition(s):FibromyalgiaLast Updated:February 25, 2013Terminated
2179
International Study to Predict Optimised Treatment – in Depression
Condition(s):Major Depressive DisorderLast Updated:July 11, 2018Unknown status
2180
Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
Condition(s):Breast Cancer; Depression; Hot Flashes; Psychosocial Effects of Cancer and Its TreatmentLast Updated:September 25, 2023Active, not recruiting